FDA: Weight-Loss Drugs Must Warn of Vision Loss
FDA: Weight-Loss Drugs Must Warn of Vision Loss
FDA: Weight-Loss Drugs Must Warn of Vision Loss
Key points
اہم نکات
मुख्य बातें
- The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports.
- The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
- The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports.
- The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
- The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports.
- The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports. The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports. The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
The US Food and Drug Administration has told makers of GLP-1 drugs to add a warning about a potential risk of vision loss, the Washington Post reports. The medicines are widely used for weight loss and diabetes, and the new warning will appear in their safety information so patients and doctors are aware of the possible eye side effect.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।